Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Haemonetics (NYSE: HAE) has announced the availability of its first quarter fiscal year 2025 financial results on its Investor Relations website. The company will host a conference call and webcast on August 8, 2024, at 8:00 a.m. ET to discuss the results with investors and analysts. Participants can access the call via a teleconference link or a live webcast. The earnings release referenced during the call is also available on the company's website. A replay of the conference call and webcast will be accessible for one year starting from August 8, 2024, at 11:00 a.m. ET.
Haemonetics (NYSE: HAE) ha annunciato la disponibilità dei risultati finanziari del primo trimestre dell'anno fiscale 2025 sul suo sito web per gli investitori. L'azienda terrà una call di conferenza e un webcast l'8 agosto 2024, alle 8:00 ET, per discutere i risultati con investitori e analisti. I partecipanti possono accedere alla chiamata tramite un link di teleconferenza o un webcast dal vivo. Il comunicato sugli utili menzionato durante la chiamata è anch'esso disponibile sul sito dell'azienda. Una registrazione della conferenza e del webcast sarà accessibile per un anno a partire dall'8 agosto 2024, alle 11:00 ET.
Haemonetics (NYSE: HAE) ha anunciado la disponibilidad de sus resultados financieros del primer trimestre del año fiscal 2025 en su sitio web de Relaciones con Inversores. La compañía realizará una llamada de conferencia y un webcast el 8 de agosto de 2024, a las 8:00 a.m. ET para discutir los resultados con inversionistas y analistas. Los participantes pueden acceder a la llamada a través de un enlace de teleconferencia o un webcast en vivo. El comunicado de ganancias mencionado durante la llamada también está disponible en el sitio web de la empresa. Una repetición de la llamada de conferencia y el webcast estará accesible durante un año a partir del 8 de agosto de 2024, a las 11:00 a.m. ET.
하이모네틱스 (NYSE: HAE)는 2025 회계연도 1분기 재무 결과를 투자자 관계 웹사이트에 발표했습니다. 이 회사는 2024년 8월 8일 오전 8시(ET)에 투자자 및 분석가와 결과를 논의하기 위한 전화 회의 및 웹캐스트를 개최할 예정입니다. 참가자는 전화 회의 링크 또는 실시간 웹캐스트를 통해 통화에 접속할 수 있습니다. 통화 중 언급된 수익 발표는 회사 웹사이트에서도 확인할 수 있습니다. 전화 회의 및 웹캐스트의 재생은 2024년 8월 8일 오전 11시(ET)부터 1년간 이용 가능합니다.
Haemonetics (NYSE: HAE) a annoncé la disponibilité de ses résultats financiers du premier trimestre de l'exercice 2025 sur son site Web des relations avec les investisseurs. L'entreprise organisera une conférence téléphonique et un webinaire le 8 août 2024 à 8h00 ET pour discuter des résultats avec des investisseurs et des analystes. Les participants peuvent accéder à l'appel via un lien de téléconférence ou un webinaire en direct. Le communiqué de presse sur les bénéfices mentionné durant l'appel est également disponible sur le site de l'entreprise. Un enregistrement de la conférence téléphonique et du webinaire sera accessible pendant un an à partir du 8 août 2024 à 11h00 ET.
Haemonetics (NYSE: HAE) hat die Verfügbarkeit seiner finanziellen Ergebnisse für das erste Quartal des Geschäftsjahres 2025 auf seiner Investor-Relations-Website bekannt gegeben. Das Unternehmen wird am 8. August 2024 um 8:00 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten, um die Ergebnisse mit Investoren und Analysten zu besprechen. Die Teilnehmer können über einen Telekonferenzlink oder einen Live-Webcast auf den Anruf zugreifen. Die während des Anrufs erwähnte Ergebnisveröffentlichung ist ebenfalls auf der Website des Unternehmens verfügbar. Eine Wiederholung der Telefonkonferenz und des Webcasts wird ab dem 8. August 2024 um 11:00 Uhr ET ein Jahr lang zugänglich sein.
- None.
- None.
Financial release accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on August 8, 2024. The conference call and webcast can be accessed with the following information:
- Teleconference link: https://register.vevent.com/register/BI5ac87cebabbb4a7aaaad3746f243431a
- Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/qeo7r49a
In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.
Direct link to 1Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/1048427c-6709-4f0f-95d3-099b50780c50
A replay of the conference call and webcast will be available for one year beginning on August 8, 2024, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302217606.html
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) release its Q1 FY2025 earnings?
When is Haemonetics (HAE) hosting its Q1 FY2025 earnings call?
How can investors access Haemonetics (HAE) Q1 FY2025 earnings call?
For how long will the replay of Haemonetics (HAE) Q1 FY2025 earnings call be available?
